Cargando…
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
miR-375 is a tumor-suppressive microRNA (miRNA) in gastric cancer (GC). However, its molecular mechanism remains unclear. The aim of this study is to comprehensively investigate how miR-375 is involved in Hippo pathway by targeting multiple oncogenes. miR-375 expression in gastric cancer cell lines...
Autores principales: | Kang, Wei, Huang, Tingting, Zhou, Yuhang, Zhang, Jinglin, Lung, Raymond W. M., Tong, Joanna H. M., Chan, Anthony W. H., Zhang, Bin, Wong, Chi Chun, Wu, Feng, Dong, Yujuan, Wang, Shiyan, Yang, Weiqin, Pan, Yi, Chak, Wing Po, Cheung, Alvin H. K., Pang, Jesse C. S., Yu, Jun, Cheng, Alfred S. L., To, Ka Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833783/ https://www.ncbi.nlm.nih.gov/pubmed/29367737 http://dx.doi.org/10.1038/s41419-017-0134-0 |
Ejemplares similares
-
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022) -
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022) -
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016) -
A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016) -
The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)